XML 31 R32.htm IDEA: XBRL DOCUMENT v3.3.0.814
Revenue Recognition - Additional Information (Detail) - USD ($)
3 Months Ended
Sep. 30, 2015
Sep. 30, 2014
Revenue Recognition [Line Items]    
Product and service revenue $ 466,000 $ 6,000
KOREA | Korean Pharmaceutical Company [Member]    
Revenue Recognition [Line Items]    
Upfront payment received $ 500,000 $ 500,000
Deferred revenue recognition period 10 years 10 years
CANADA | Canadian-based Supplier [Member]    
Revenue Recognition [Line Items]    
Upfront payment received $ 250,000 $ 250,000
Deferred revenue recognition period 7 years 7 years